+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Novolin N"

US Diabetes Drug Market, Dosage, Price, Sales Insight 2021 - 2026 - Product Thumbnail Image

US Diabetes Drug Market, Dosage, Price, Sales Insight 2021 - 2026

  • Report
  • February 2021
  • 500 Pages
  • United States
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Novolin N is a brand of human insulin used to treat diabetes mellitus, a metabolic disorder. It is a short-acting insulin that is used to control high blood sugar levels in people with type 1 and type 2 diabetes. Novolin N is a clear, colorless solution that is injected subcutaneously. It is used in combination with other diabetes medications to help control blood sugar levels. Novolin N is available in vials, cartridges, and pens. It is also available in combination with other diabetes medications, such as NovoLog and NovoRapid. Novolin N is part of the Endocrine and Metabolic Disorders Drugs market, which includes medications used to treat a variety of endocrine and metabolic disorders, such as diabetes, thyroid disorders, and obesity. These medications are used to control blood sugar levels, regulate hormones, and reduce the risk of complications associated with metabolic disorders. Companies in the Novolin N market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Pfizer. Show Less Read more